Cash Transfers for People Experiencing Homelessness

Sponsor
University of British Columbia (Other)
Overall Status
Recruiting
CT.gov ID
NCT05372978
Collaborator
Foundations for Social Change (Other)
400
1
2
19
21.1

Study Details

Study Description

Brief Summary

The primary goal of the study is to determine the impacts of a one-time unconditional cash transfer on the well-being of people experiencing homelessness.

Condition or Disease Intervention/Treatment Phase
  • Behavioral: Cash transfer
N/A

Detailed Description

The goal of this project is to examine the effect of cash-transfers for people experiencing homelessness in Metro Vancouver. In partnership with Foundations for Social Change, we will distribute a one-time unconditional cash transfer of $8,500 to each of the 200 participants, with 200 additional participants in a control group who will not receive the cash transfer. To evaluate the effect of the cash transfer, participants will complete surveys 1, 2, 3, 6, 9, and 12 months after the cash transfer, and we will track important life outcomes such as housing, employment, health, cognitive function, and well-being.

Study Design

Study Type:
Interventional
Anticipated Enrollment :
400 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Intervention Model Description:
Participants will be randomly assigned to condition (cash vs control).Participants will be randomly assigned to condition (cash vs control).
Masking:
None (Open Label)
Primary Purpose:
Treatment
Official Title:
Cash Transfers for People Experiencing Homelessness
Actual Study Start Date :
May 2, 2022
Anticipated Primary Completion Date :
Dec 1, 2023
Anticipated Study Completion Date :
Dec 1, 2023

Arms and Interventions

Arm Intervention/Treatment
Experimental: Cash

Participants will receive a one-time unconditional cash transfer of $8,500 CAD.

Behavioral: Cash transfer
Participants will receive a one-time unconditional cash transfer of $8,500.

No Intervention: Control

Participants will not receive a cash transfer.

Outcome Measures

Primary Outcome Measures

  1. Stable housing [1-3 months]

    Number of days spent in stable housing.

  2. Homelessness [1-3 months]

    Number of days spent homeless.

  3. Savings [1-3 months]

    Total value of financial assets.

  4. Total Spending [1-3 months]

    Amount of money spent on regular and one-time purchases.

  5. Spending on Rent [1-3 months]

    Amount of money spent on rent.

  6. Spending on temptation goods [1-3 months]

    Amount of money spent on temptation goods, such as drugs, alcohol, and cigarettes.

  7. Cost of shelter use [1-3 months]

    Estimated societal cost of shelter use based on number of days staying in shelter

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years to 65 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
  1. Participants must be homeless at the time of recruitment.

  2. Participants must be between 18 and 65 years of age, inclusive.

  3. Participants must be a Canadian citizen or permanent resident in Canada

Exclusion Criteria:
The following participants will be excluded:
  1. Participants who report severe problematic substance use (score ≥ 6 on DAST).

  2. Participants who report severe problematic alcohol use (score ≥ 20 on AUDIT).

  3. Participants who report severe psychiatric symptoms (score above 2 on item 5 or above 4 on items 13 or 14 on CSI).

  4. Participants who report problematic gambling behavior (score ≥ 8 on PGSI).

Contacts and Locations

Locations

Site City State Country Postal Code
1 University of British Columbia Vancouver British Columbia Canada

Sponsors and Collaborators

  • University of British Columbia
  • Foundations for Social Change

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Jiaying Zhao, Associate Professor, University of British Columbia
ClinicalTrials.gov Identifier:
NCT05372978
Other Study ID Numbers:
  • H21-02584
First Posted:
May 13, 2022
Last Update Posted:
May 13, 2022
Last Verified:
May 1, 2022
Individual Participant Data (IPD) Sharing Statement:
Yes
Plan to Share IPD:
Yes
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No

Study Results

No Results Posted as of May 13, 2022